ChartMill · Nov 13, 2026
Humana (NYSE:HUM) Nears Breakout With Perfect Technical and Setup Scores
Humana (HUM) scores perfect 10 technical and setup ratings, trades near 52-week highs, and eyes a breakout above 451.01 with defined support risk.

NASDAQ · HUM
Healthcare · Medical - Healthcare Plans
$380.00
Down-$5.78 (-1.50%)
Updated Nov 20, 2026, 2:20 AM
SID Score
6.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · HUM
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
HUM closed at $380.00 after 21 trading sessions, down 9.73% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $392.72 | $393.45 | $373.17 | $380.00 | 1.94M |
| Nov 18, 2026 | $441.44 | $443.52 | $384.61 | $385.78 | 4.16M |
| Nov 17, 2026 | $447.00 | $447.00 | $431.78 | $443.34 | 1.89M |
| Nov 16, 2026 | $460.00 | $462.869 | $449.08 | $461.25 | 1.31M |
| Nov 13, 2026 | $445.69 | $451.04 | $435.39 | $450.00 | 1.5M |
| Nov 12, 2026 | $450.00 | $450.00 | $434.09 | $443.68 | 1.94M |
| Nov 11, 2026 | $443.02 | $451.00 | $439.23 | $446.31 | 2.5M |
| Nov 10, 2026 | $425.36 | $443.03 | $422.63 | $438.06 | 2.11M |
| Nov 9, 2026 | $438.57 | $448.44 | $422.33 | $423.22 | 2.45M |
| Nov 6, 2026 | $415.00 | $444.00 | $411.555 | $433.74 | 2.58M |
| Nov 5, 2026 | $417.47 | $423.965 | $405.40 | $411.79 | 1.36M |
| Nov 4, 2026 | $414.38 | $427.065 | $404.18 | $417.42 | 1.86M |
| Nov 3, 2026 | $407.87 | $422.65 | $405.45 | $417.87 | 1.37M |
| Nov 2, 2026 | $420.64 | $420.64 | $399.35 | $410.41 | 917.99K |
| Oct 30, 2026 | $415.66 | $420.35 | $409.44 | $414.50 | 887.97K |
| Oct 29, 2026 | $416.11 | $418.56 | $408.79 | $417.56 | 1.02M |
| Oct 28, 2026 | $416.00 | $421.95 | $410.95 | $411.87 | 1.05M |
| Oct 27, 2026 | $416.66 | $420.025 | $411.58 | $414.85 | 697.31K |
| Oct 26, 2026 | $426.27 | $430.15 | $415.26 | $417.22 | 1.3M |
| Oct 23, 2026 | $420.60 | $425.925 | $417.00 | $422.07 | 1.2M |
| Oct 22, 2026 | $423.16 | $428.305 | $417.49 | $420.97 | 1.81M |
The latest Smart Investors Daily articles mentioning HUM.
Company
Market Activity
Research & News
HUM research
Company profile and research snapshot.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 12, 2026 | Wells Fargo | Overweight | — |
| Nov 11, 2026 | TD Cowen | Hold | — |
| Nov 10, 2026 | JP Morgan | Neutral | — |
| Nov 9, 2026 | Cantor Fitzgerald | Overweight | — |
| Nov 9, 2026 | Barclays | Overweight | — |
No generated briefing is available yet.
ChartMill · Nov 13, 2026
Humana (HUM) scores perfect 10 technical and setup ratings, trades near 52-week highs, and eyes a breakout above 451.01 with defined support risk.
Yahoo · Nov 12, 2026
SCOTTSDALE, Ariz., November 12, 2026--Enterprises are racing to put AI to work, but many still can't account for what it costs or how it uses company data to make decisions across disparate systems. Today Axway, a 74Software company (Euronext: 74SW) trusted by more than 4,000 organizations, introduced Amplify Platform to close that gap. The platform gives enterprises, including those in highly regulated industries, a foundation to securely connect, govern and orchestrate the APIs, integrations,
Benzinga · Nov 12, 2026
Wells Fargo analyst Stephen Baxter maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $502 to $602.
Yahoo · Nov 11, 2026
The latest valuation work on Humana lifts the assessed fair value from US$465.13 to US$475.54, signaling a modest reset in price targets. Analysts linking this move to recent Q3 results and improved Medicare Advantage Star Ratings describe a generally constructive mood, even as some still flag policy and execution risks. Read on to see what is driving the shifting Humana story and how you can track the next turns in this narrative. Analyst Price Targets don't always capture the full story...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HUM.